Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neuro Medtech Investors Have Time (And Money) For The Pain

This article was originally published in Start Up

Executive Summary

START-UP reviews five years of fundraising and exit activities for privately held medtech and diagnostics companies developing neurology treatments. Part 2 of our series on neuro-focused capital raising and bow-outs.

Advertisement

Related Content

OUS Approvals Analysis: Expanded CoreValve Indication And Zika IVDs Among August’s CE Marks
Neuromodulation: Three Start-Ups To Watch
US Neurostimulation Devices Market Forecast to Grow By $1B+ With New Indications, New Technologies
Neuromodulation 2015: Innovation Expands Opportunities In Chronic Pain

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT038006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel